Avalon GloboCare shares surge 16.03% after-hours after completing $2.8M private placement to fund operations and debt repayment.

Avalon GloboCare surged 16.03% in after-hours trading following the announcement of a completed private placement that raised $2.8 million in net proceeds. The deal, finalized on Feb. 27, 2026, involved the issuance of common stock, pre-funded warrants, and Series A-1/A-2 warrants priced at $0.51 per share, with up to $6.5 million in additional potential proceeds if all warrants are exercised. The funds will be used to repay debt and support working capital, addressing liquidity needs for the company’s AI and medical technology operations. The transaction, led by H.C. Wainwright & Co. and Roth Capital Partners, includes measures to limit investor concentration and provides resale liquidity through registered shares. The after-hours rally reflects investor optimism over the capital raise, which aligns with Avalon’s strategy to strengthen its balance sheet while advancing its diversified portfolio in precision diagnostics and enterprise AI.